At the Regina Elena the first endoscopic mastectomy with immediate reconstruction
The milestone achieved in a public facility in Lazio starts a new phase for oncological senology that is more precise and respectful of the female body
by Claudio Botti*.
-U64401155610brZ-1440x752@IlSole24Ore-Web.jpeg?r=650x341)
2' min read
Key points
2' min read
A new milestone for breast cancer surgery has been reached at the Regina Elena Institute in Rome: we have performed the first nipple-sparing mastectomy with a completely endoscopic technique and immediate reconstruction with prosthesis, within a public facility in Lazio. An operation that marks the start of a new phase for oncological senology: more precise, more respectful of the female body, and closer to the needs of patients.
This innovation, realised by a multidisciplinary team of breast and plastic surgeons, is the result of years of joint work, study and technical refinement. Our goal is clear: to integrate oncological safety with the highest possible quality of life, guaranteeing personalised, minimally invasive and high-tech treatments.
Reduced surgical trauma and post-operative pain
.The endoscopic technique allows us to remove breast tissue through a small incision of only 3-4 centimetres - about half the size of traditional methods - while preserving the skin, areola and nipple. Through the same opening, we can proceed with the insertion of the prosthesis, completing the breast reconstruction in a single time. This approach significantly reduces surgical trauma, post-operative pain and recovery time. In addition, it allows for greater nipple sensitivity and more natural aesthetic results, improving the patient's acceptance of her body.
From a technical point of view, we use an endoscope equipped with a camera and light, and operating tools introduced through devices (single port), which allows us to work with millimetric precision even in small spaces, with virtually invisible aesthetic impact.
The central role of new technologies
.Implementations with new 3D vision, artificial intelligence (AI) and intraoperative fluorescence technologies are also planned. The surgical field is no longer just 'looked at' but experienced by distinguishing with greater anatomical and functional detail the tissues to be removed and those to be preserved. This integration moves oncological breast surgery together with reconstructive surgery, which is constantly evolving, from a standardised to a customised approach.
